Intelligence Platform
Patents
Browse 86 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12383733
Iontophoresis-based patch type medicine absorption device
granted patentUS 12365879
Synthetic chimeric poxviruses
granted patentUS 12304901
Selective ligands for tau aggregates
granted patentUS 12156897
Magnesium-containing oxytocin formulations and methods of use
granted patentUS 12156864
Analogs of cyclobenzaprine and amitryptilene
granted patentUS 12097183
Pharmaceutical composition for treating migraine
granted patentUS 12090139
Formulations comprising triptan compounds
granted patentUS 11998516
Methods and compositions for treating depression using cyclobenzaprine
granted patentUS 11975161
Drug releasing coatings for balloon catheters
granted patentUS 11970554
Labeled oxytocin and method of manufacture and use
granted patentUS 11839594
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted patentUS 11826321
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and n
granted patentUS 11737991
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
granted patentUS 11566032
Radio-protective and chemo-protective substituted thiols
granted patentUS 11534430
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and an
granted patentUS 11517557
Analogs of cyclobenzaprine and amitriptyline
granted patentUS 11389473
Magnesium-containing oxytocin formulations and methods of use
granted patentUS 11376404
Drug releasing coatings for medical devices
granted patentUS 11026898
Eutectic formulations of cyclobenzaprine hydrochloride
granted patentUS 10994055
Drug releasing coatings for medical devices
granted patentUS 10946027
Tianeptine oxalate salts and polymorphs
granted patentUS 10912931
Drug releasing coatings for balloon catheters
granted patentUS 10912932
Drug releasing coatings for balloon catheters
granted patentUS 10881644
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and an
granted